Low THC cannabis products in the EU
We will provide an overview of the legal framework of the UN drug control conventions related to the unauthorised sale of ‘cannabis flowers’ and ‘extracts and tinctures of cannabis’. We will briefly introduce the outcomes of the WHO expert committee which recently recommended that pure CBD should not be listed under the drug conventions.
We will then analyse the EU common agricultural policy presenting the directives and regulations addressing the sale of low-THC products to contextualize the different legal responses of EU countries towards low-THC products in terms of THC thresholds, authorized varieties and general limits in the means of consumption. We will identify other potential details which condition the legality and classification of CBD product, such as the quantitative limits to CBD. Finally, we will provide an overview of the legality of the product marketing which generally depends on the source of the CBD, the format of the product and how it is presented.